PMID: 3750243May 1, 1986Paper

Effect of aerosol particle size on bronchodilatation with nebulised terbutaline in asthmatic subjects

Thorax
M M ClayS W Clarke

Abstract

The bronchodilatation achieved by the beta 2 agonist terbutaline sulphate given as nebulised aerosol from different devices has been measured in seven patients with mild asthma (mean FEV1 76% predicted) over two hours after inhalation. The subjects were studied on four occasions. On three visits they received 2.5 mg terbutaline delivered from three different types of nebuliser, selected on the basis of the size distribution of the aerosols generated; and on a fourth (control) visit no aerosol was given. The size distributions of the aerosols expressed in terms of their mass median diameter (MMD) were: A: MMD 1.8 microns; B: 4.6 microns; C: 10.3 microns. The aerosols were given under controlled conditions of respiratory rate and tidal volume to minimise intertreatment variation. Bronchodilator response was assessed by changes in FEV1, forced vital capacity (FVC), peak expiratory flow (PEF), and maximal flow after expiration of 50% and 75% FVC (Vmax50, Vmax25) from baseline (before aerosol) and control run values. For each pulmonary function index all three aerosols gave significantly better improvement over baseline than was seen in the control (p less than 0.05) and had an equipotent effect on FEV1, FVC, and PEF. Aerosol A (MMD...Continue Reading

References

Dec 1, 1978·Thorax·R E RuffinM T Newhouse
Nov 1, 1978·Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology·M J HensleyR H Ingram
Jan 5, 1985·British Medical Journal·J G DouglasI W Grant
Feb 1, 1974·Clinical Science and Molecular Medicine·S GodfreyJ H Bell

❮ Previous
Next ❯

Citations

May 1, 1996·Pediatric Pulmonology·J MallolC F Robertson
May 1, 1991·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·Q A Summers
Sep 1, 1989·Archives of Disease in Childhood·C O'CallaghanA D Milner
Oct 1, 1994·Archives of Disease in Childhood·S FurfaroM Robert
Apr 1, 1997·Thorax·C O'Callaghan, P W Barry
Jun 2, 1998·American Journal of Respiratory and Critical Care Medicine·P J Thompson
Jun 2, 1998·American Journal of Respiratory and Critical Care Medicine·P H Howarth
Feb 1, 1990·The American Review of Respiratory Disease·P PatelA F Wilson
Jan 10, 2008·AAPS PharmSciTech·Jolyon MitchellHak-Kim Chan
Nov 1, 1993·Experimental Lung Research·M AndersonP Camner
Apr 7, 2004·Journal of Pharmaceutical Sciences·Gabriela Sbirlea-ApiouTed Martonen
Jul 13, 2002·Journal of Pharmaceutical Sciences·Cynthia J MusanteTed B Martonen
Jun 1, 1992·Pulmonary Pharmacology·C HultquistB Jonson
Jan 1, 1989·Pediatric Pulmonology·C J Newth, A R Clark
Feb 25, 1998·Respiratory Medicine·H Bisgaard
Jul 13, 2002·Respiratory Medicine·S P Newman, W W Busse
Jun 23, 2009·Respiratory Medicine·Karen G SchueeppJohannes H Wildhaber
Jan 1, 1997·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·H Bisgaard
Aug 5, 2003·Journal of Applied Physiology·Omar S UsmaniPeter J Barnes
Aug 4, 1998·Journal of Applied Physiology·D A EdwardsR Langer
Apr 1, 1997·The Annals of Pharmacotherapy·J C Joseph
May 5, 2021·Journal of Aerosol Medicine and Pulmonary Drug Delivery·Henrik WatzLeonardo M Fabbri

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.